Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Kansas City University of Medicine and Biosciences |
---|---|
Information provided by: | Kansas City University of Medicine and Biosciences |
ClinicalTrials.gov Identifier: | NCT00742989 |
The goal of this project is to see how much an osteopathic lymphatic treatment (OLT) causes an increase in plasma volume, total plasma protein concentration, and albumin concentration. This is an important step in understanding the effects of OLT, specifically its effects on fluid in the body. The primary role of the lymph system is the return of fluid and proteins lost from the blood vessels. Despite this, no research has been done to see what effects an OLT has on fluid and protein levels in the blood.
Condition | Intervention |
---|---|
Healthy Volunteers |
Other: OLT maneuver Other: Sham OLT |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Placebo Control, Crossover Assignment |
Official Title: | The Short-Term Effect of Osteopathic Lymphatic Treatment on Blood Cell Count, Plasma Protein, and Blood Pressure: A Pilot Study in a Cross-Over Design |
Enrollment: | 15 |
Study Start Date: | May 2005 |
Study Completion Date: | July 2006 |
Primary Completion Date: | July 2005 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental
OLT administration
|
Other: OLT maneuver
direct myofascial release for the thoracic inlet for 30 seconds, supine rib raising for 1 minute on each side of the body, thoracic pumping for one minute, thoracic vacuum for 30 seconds, doming of the abdominal diaphragm for 30 seconds, abdominal pumping for 1 minute, pedal pumping for 1 minute, a second thoracic pump for 1 minute, a second thoracic vacuum for 30 seconds, and a final direct myofascial release for the thoracic inlet lasting 30 seconds
|
B: Sham Comparator
placebo-OLT
|
Other: Sham OLT
Therapeutic massage performed
|
Ages Eligible for Study: | 20 Years to 40 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Missouri | |
Dybedal Clinical Research Center, Kansas City University of Medicine and Biosciences | |
Kansas City, Missouri, United States, 64106 |
Principal Investigator: | W. Evan Rivers, DO | Kansas City University of Medicine and Biosciences |
Study Director: | Charlott L. Williiams, RN, CCRC | Kansas City University of Medicine and Biosciences |
Study Director: | Alan G. Glaros, PhD | KCUMB |
Study Chair: | Kevin Treffer, DO | KCUMB |
Responsible Party: | Kansas City University of Medicine and Biosciences ( Patrick G. Clay, PharmD, Director, Dybedal Center for Clinical Research ) |
Study ID Numbers: | KCUMB-2005-01 |
Study First Received: | August 26, 2008 |
Last Updated: | August 27, 2008 |
ClinicalTrials.gov Identifier: | NCT00742989 |
Health Authority: | United States: Institutional Review Board |
osteopathic lymphatic treatment OLT normal |
Healthy |